Sign in

CIK 0001513525

  • Non-accelerated filer
  • Smaller reporting company

Azora Therapeutics, Inc. (DE)

Sign in to watch
Ticker
AZR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
800667150
Phone
+1 434-422-9800
Business address
16501 VENTURA BLVD, SUITE 400, ENCINO, CA, 91436
Former names
ADIAL PHARMACEUTICALS, INC., Adial Pharmaceuticals, L.L.C., ADial Pharmaceuticals, L.L.C.
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market buy Director bought 700 shares at $2.74 ($1,918)
  3. 4 Derivatives Options or other derivatives
  4. 4 Grant or award Chief Financial Officer acquired 157,500 shares (grant or award)
  5. 4 Grant or award Director acquired 240,800 shares (grant or award)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Grant or award Chief Executive Officer acquired 420,000 shares (grant or award)
  11. 4 Derivatives Options or other derivatives
  12. 4 Returned to the company Director returned 166,667 shares (to the company)
  13. 4 Grant or award Chief Executive Officer acquired 100,000 shares (grant or award)
  14. 4 Derivatives Options or other derivatives
  15. 4 Grant or award Chief Executive Officer acquired 1,000,000 shares (grant or award)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Grant or award Chief Executive Officer acquired 250,000 shares (grant or award)

Page 3 of 7 · 123 filings